{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T17:12:57Z","timestamp":1784394777079,"version":"3.55.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,5,18]],"date-time":"2025-05-18T00:00:00Z","timestamp":1747526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,5,18]],"date-time":"2025-05-18T00:00:00Z","timestamp":1747526400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Universit\u00e0 degli Studi di Roma La Sapienza"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Saf"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s40264-025-01555-4","type":"journal-article","created":{"date-parts":[[2025,5,18]],"date-time":"2025-05-18T12:36:24Z","timestamp":1747571784000},"page":"1079-1088","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Risk of New-Onset Atrial Fibrillation in Opioid Users: A Systematic Review and Meta-Analysis on 24,006,367 Participants"],"prefix":"10.1007","volume":"48","author":[{"given":"Danilo","family":"Menichelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Gazzaniga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianna","family":"Pannunzio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria Maria","family":"Palumbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianna","family":"Pani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Pignatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Valeriani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6357-5213","authenticated-orcid":false,"given":"Daniele","family":"Pastori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,18]]},"reference":[{"key":"1555_CR1","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/978-981-33-6009-9_12","volume-title":"Introduction to basics of pharmacology and toxicology. Essentials of systemic pharmacology: from principles to practice","author":"S Kumar","year":"2021","unstructured":"Kumar S, Itagi S. Opioid agonists and antagonists. In: Paul A, Anandabaskar N, Mathaiyan J, Raj GM, editors. Introduction to basics of pharmacology and toxicology. Essentials of systemic pharmacology: from principles to practice, vol. 2. Singapore: Springer Nature Singapore; 2021. p. 213\u201335."},{"key":"1555_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2021.101198","volume":"42","author":"S Jayawardana","year":"2021","unstructured":"Jayawardana S, Forman R, Johnston-Webber C, Campbell A, Berterame S, de Joncheere C, et al. Global consumption of prescription opioid analgesics between 2009\u20132019: a country-level observational study. EClinicalMedicine. 2021;42: 101198.","journal-title":"EClinicalMedicine."},{"issue":"6","key":"1555_CR3","doi-asserted-by":"publisher","first-page":"R128","DOI":"10.1186\/cc6195","volume":"11","author":"CJ Longo","year":"2007","unstructured":"Longo CJ, Heyland DK, Fisher HN, Fowler RA, Martin CM, Day AG. A long-term follow-up study investigating health-related quality of life and resource use in survivors of severe sepsis: comparison of recombinant human activated protein C with standard care. Crit Care. 2007;11(6):R128.","journal-title":"Crit Care"},{"issue":"8","key":"1555_CR4","doi-asserted-by":"crossref","DOI":"10.1161\/HCQ.0000000000000131","volume":"17","author":"KE Di Palo","year":"2024","unstructured":"Di Palo KE, Feder S, Baggenstos YT, Cornelio CK, Forman DE, Goyal P, et al. Palliative pharmacotherapy for cardiovascular disease: a scientific statement from the American Heart Association. Circ Cardiovasc Qual Outcomes. 2024;17(8): e000131.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"13","key":"1555_CR5","doi-asserted-by":"publisher","first-page":"e218","DOI":"10.1161\/CIR.0000000000001007","volume":"144","author":"SL Chow","year":"2021","unstructured":"Chow SL, Sasson C, Benjamin IJ, Califf RM, Compton WM, Oliva EM, et al. Opioid use and its relationship to cardiovascular disease and brain health: a presidential advisory from the American Heart Association. Circulation. 2021;144(13):e218\u201332.","journal-title":"Circulation"},{"issue":"10 Suppl.","key":"1555_CR6","first-page":"S200","volume":"24","author":"NE Hagemeier","year":"2018","unstructured":"Hagemeier NE. Introduction to the opioid epidemic: the economic burden on the healthcare system and impact on quality of life. Am J Manag Care. 2018;24(10 Suppl.):S200\u20136.","journal-title":"Am J Manag Care"},{"issue":"4","key":"1555_CR7","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1136\/emj.2007.050419","volume":"25","author":"WF Peacock","year":"2008","unstructured":"Peacock WF, Hollander JE, Diercks DB, Lopatin M, Fonarow G, Emerman CL. Morphine and outcomes in acute decompensated heart failure: an ADHERE analysis. Emerg Med J. 2008;25(4):205\u20139.","journal-title":"Emerg Med J"},{"issue":"5","key":"1555_CR8","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1159\/000492616","volume":"27","author":"M Behzadi","year":"2018","unstructured":"Behzadi M, Joukar S, Beik A. Opioids and cardiac arrhythmia: a literature review. Med Princ Pract. 2018;27(5):401\u201314.","journal-title":"Med Princ Pract"},{"key":"1555_CR9","doi-asserted-by":"crossref","unstructured":"Golibkhon A, Akbar Gafur Ugli B, Makhamadjonov Farkhod Ugli M. Opioid agents and cardiac arrhythmia: a literature review. Cureus. 2023;15(4):e38007.","DOI":"10.7759\/cureus.38007"},{"issue":"9","key":"1555_CR10","volume":"15","author":"E Toska","year":"2023","unstructured":"Toska E, Mayrovitz HN. Opioid impacts on cardiovascular health. Cureus. 2023;15(9): e46224.","journal-title":"Cureus."},{"issue":"6","key":"1555_CR11","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1001\/jamainternmed.2015.1045","volume":"175","author":"WT Qureshi","year":"2015","unstructured":"Qureshi WT, O\u2019Neal WT, Khodneva Y, Judd S, Safford MM, Muntner P, et al. Association between opioid use and atrial fibrillation: the reasons for geographic and racial differences in stroke (REGARDS) study. JAMA Intern Med. 2015;175(6):1058\u201360.","journal-title":"JAMA Intern Med"},{"key":"1555_CR12","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ahj.2023.11.001","volume":"268","author":"PW Chui","year":"2024","unstructured":"Chui PW, Khokhar A, Gordon KS, Dziura J, Burg MM, Brandt C, et al. Opioid prescription and risk of atrial fibrillation in younger veterans. Am Heart J. 2024;268:61\u20137.","journal-title":"Am Heart J"},{"issue":"10","key":"1555_CR13","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1093\/europace\/euab065","volume":"23","author":"J Steffel","year":"2021","unstructured":"Steffel J, Collins R, Antz M, Cornu P, Desteghe L, Haeusler KG, et al. 2021 European Heart Rhythm Association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Europace. 2021;23(10):1612\u201376.","journal-title":"Europace"},{"issue":"8","key":"1555_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacadv.2024.101117","volume":"3","author":"D Menichelli","year":"2024","unstructured":"Menichelli D, Pignatelli P, Brogi T, Pannunzio A, Violi F, Lip GYH, et al. Incidence of all-cause, cardiovascular, and atrial fibrillation-related hospitalizations: focus on antiarrhythmic drugs. JACC Adv. 2024;3(8): 101117.","journal-title":"JACC Adv."},{"issue":"5","key":"1555_CR15","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"G Hindricks","year":"2021","unstructured":"Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomstrom-Lundqvist C, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the Diagnosis and Management of Atrial Fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42(5):373\u2013498.","journal-title":"Eur Heart J"},{"issue":"7","key":"1555_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacadv.2023.100555","volume":"2","author":"DGG Pastori","year":"2023","unstructured":"Pastori DGG, Farcomeni A, Bucci T, Menichelli D, Franchino G, Pani A, et al. Venous thromboembolism in patients with atrial fibrillation: a systematic review and meta-analysis of 4,170,027 patients. JACC Adv. 2023;2(7): 100555.","journal-title":"JACC Adv."},{"issue":"1","key":"1555_CR17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41572-022-00336-y","volume":"8","author":"AA Khorana","year":"2022","unstructured":"Khorana AA, Mackman N, Falanga A, Pabinger I, Noble S, Ageno W, et al. Cancer-associated venous thromboembolism. Nat Rev Dis Primers. 2022;8(1):11.","journal-title":"Nat Rev Dis Primers"},{"issue":"12","key":"1555_CR18","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1002\/cncr.33470","volume":"127","author":"D Pastori","year":"2021","unstructured":"Pastori D, Marang A, Bisson A, Menichelli D, Herbert J, Lip GYH, et al. Thromboembolism, mortality, and bleeding in 2,435,541 atrial fibrillation patients with and without cancer: a nationwide cohort study. Cancer. 2021;127(12):2122\u20139.","journal-title":"Cancer"},{"issue":"1","key":"1555_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2046-4053-4-1","volume":"4","author":"D Moher","year":"2015","unstructured":"Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4(1):1.","journal-title":"Syst Rev"},{"issue":"372","key":"1555_CR20","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"29","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;29(372): n71.","journal-title":"BMJ"},{"issue":"355","key":"1555_CR21","volume":"12","author":"JA Sterne","year":"2016","unstructured":"Sterne JA, Hernan MA, Reeves BC, Savovic J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ (Clin Res Ed). 2016;12(355): i4919.","journal-title":"BMJ (Clin Res Ed)."},{"issue":"1","key":"1555_CR22","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/jrsm.1411","volume":"12","author":"LA McGuinness","year":"2021","unstructured":"McGuinness LA, Higgins JPT. Risk-of-bias VISualization (robvis): an R package and Shiny web app for visualizing risk-of-bias assessments. Res Synth Methods. 2021;12(1):55\u201361.","journal-title":"Res Synth Methods."},{"issue":"47","key":"1555_CR23","doi-asserted-by":"publisher","first-page":"4933","DOI":"10.1093\/eurheartj\/ehac558","volume":"43","author":"AL Lin","year":"2022","unstructured":"Lin AL, Nah G, Tang JJ, Vittinghoff E, Dewland TA, Marcus GM. Cannabis, cocaine, methamphetamine, and opiates increase the risk of incident atrial fibrillation. Eur Heart J. 2022;43(47):4933\u201342.","journal-title":"Eur Heart J"},{"issue":"9","key":"1555_CR24","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1002\/pds.5036","volume":"29","author":"BN Harding","year":"2020","unstructured":"Harding BN, Wiggins KL, Jensen PN, McKnight B, Psaty BM, Heckbert SR, et al. Opioid, gabapentinoid, and nonsteroidal anti-inflammatory medication use and the risks of atrial fibrillation and supraventricular ectopy in the multi-ethnic study of atherosclerosis. Pharmacoepidemiol Drug Saf. 2020;29(9):1175\u201382.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"11","key":"1555_CR25","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003102","volume":"95","author":"CW Lee","year":"2016","unstructured":"Lee CW, Muo CH, Liang JA, Lin MC, Kao CH. Atrial fibrillation is associated with morphine treatment in female breast cancer patients: a retrospective population-based time-dependent cohort study. Medicine (Baltimore). 2016;95(11): e3102.","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"1555_CR26","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/ejp.1291","volume":"23","author":"C Chenaf","year":"2019","unstructured":"Chenaf C, Kabore JL, Delorme J, Pereira B, Mulliez A, Zenut M, et al. Prescription opioid analgesic use in France: trends and impact on morbidity-mortality. Eur J Pain. 2019;23(1):124\u201334.","journal-title":"Eur J Pain"},{"key":"1555_CR27","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.pcad.2021.04.004","volume":"66","author":"D Menichelli","year":"2021","unstructured":"Menichelli D, Vicario T, Ameri P, Toma M, Violi F, Pignatelli P, et al. Cancer and atrial fibrillation: epidemiology, mechanisms, and anticoagulation treatment. Progr Cardiovasc Dis. 2021;66:28\u201336.","journal-title":"Progr Cardiovasc Dis."},{"key":"1555_CR28","doi-asserted-by":"crossref","unstructured":"Qin P, Nicholl BI, Ho FK, Hanlon P, Celis-Morales CA, Pell JP. Association between pain and incident arrhythmias in 422,654 individuals: evidence from the UK Biobank cohort. Eur J Prev Cardiol. 2025:zwaf153.","DOI":"10.1093\/eurjpc\/zwaf153"},{"issue":"25","key":"1555_CR29","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1093\/eurheartj\/ehae222","volume":"45","author":"Q Chen","year":"2024","unstructured":"Chen Q, van Rein N, van der Hulle T, Heemelaar JC, Trines SA, Versteeg HH, et al. Coexisting atrial fibrillation and cancer: time trends and associations with mortality in a nationwide Dutch study. Eur Heart J. 2024;45(25):2201\u201313.","journal-title":"Eur Heart J"},{"issue":"2","key":"1555_CR30","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1245\/s10434-022-12690-y","volume":"30","author":"K Inoue","year":"2023","unstructured":"Inoue K, Tajiri K, Xu D, Murakoshi N, Ieda M. Risk factors and in-hospital outcomes of perioperative atrial fibrillation for patients with cancer: a meta-analysis. Ann Surg Oncol. 2023;30(2):711\u201321.","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"1555_CR31","doi-asserted-by":"publisher","first-page":"230","DOI":"10.2174\/138945012799201612","volume":"13","author":"Y Feng","year":"2012","unstructured":"Feng Y, He X, Yang Y, Chao D, Lazarus LH, Xia Y. Current research on opioid receptor function. Curr Drug Targets. 2012;13(2):230\u201346.","journal-title":"Curr Drug Targets"},{"issue":"7","key":"1555_CR32","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1016\/S0735-1097(00)01011-1","volume":"36","author":"SP Bell","year":"2000","unstructured":"Bell SP, Sack MN, Patel A, Opie LH, Yellon DM. Delta opioid receptor stimulation mimics ischemic preconditioning in human heart muscle. J Am Coll Cardiol. 2000;36(7):2296\u2013302.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"1555_CR33","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.jacc.2020.11.002","volume":"77","author":"MJ Krantz","year":"2021","unstructured":"Krantz MJ, Palmer RB, Haigney MCP. Cardiovascular complications of opioid use: JACC state-of-the-art review. J Am Coll Cardiol. 2021;77(2):205\u201323.","journal-title":"J Am Coll Cardiol"},{"issue":"Suppl. 1","key":"1555_CR34","first-page":"S275","volume":"28","author":"U Lendeckel","year":"2005","unstructured":"Lendeckel U, Muller C, Rocken C, Laube B, Tager M, Huth C, et al. Expression of opioid receptor subtypes and their ligands in fibrillating human atria. Pacing Clin Electrophysiol. 2005;28(Suppl. 1):S275\u20139.","journal-title":"Pacing Clin Electrophysiol"},{"issue":"10","key":"1555_CR35","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/0022-2828(90)90080-L","volume":"22","author":"TM Wong","year":"1990","unstructured":"Wong TM, Lee AY, Tai KK. Effects of drugs interacting with opioid receptors during normal perfusion or ischemia and reperfusion in the isolated rat heart: an attempt to identify cardiac opioid receptor subtype(s) involved in arrhythmogenesis. J Mol Cell Cardiol. 1990;22(10):1167\u201375.","journal-title":"J Mol Cell Cardiol"},{"issue":"10","key":"1555_CR36","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1056\/NEJMra032426","volume":"350","author":"DM Roden","year":"2004","unstructured":"Roden DM. Drug-induced prolongation of the QT interval. N Engl J Med. 2004;350(10):1013\u201322.","journal-title":"N Engl J Med"},{"issue":"1","key":"1555_CR37","doi-asserted-by":"publisher","first-page":"27","DOI":"10.2174\/1573403X1201160126122405","volume":"12","author":"EF Wedam","year":"2016","unstructured":"Wedam EF, Haigney MC. The impact of opioids on cardiac electrophysiology. Curr Cardiol Rev. 2016;12(1):27\u201336.","journal-title":"Curr Cardiol Rev"},{"issue":"13","key":"1555_CR38","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.012546","volume":"8","author":"YG Li","year":"2019","unstructured":"Li YG, Bisson A, Bodin A, Herbert J, Grammatico-Guillon L, Joung B, et al. C2 HEST score and prediction of incident atrial fibrillation in poststroke patients: a French nationwide study. J Am Heart Assoc. 2019;8(13): e012546.","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"1555_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr7103a1","volume":"71","author":"D Dowell","year":"2022","unstructured":"Dowell D, Ragan KR, Jones CM, Baldwin GT, Chou R. CDC Clinical practice guideline for prescribing opioids for pain: United States, 2022. MMWR Recomm Rep. 2022;71(3):1\u201395.","journal-title":"MMWR Recomm Rep"},{"issue":"6","key":"1555_CR40","doi-asserted-by":"publisher","first-page":"502","DOI":"10.2174\/1570161114666160728093323","volume":"14","author":"C Kontogiorgis","year":"2016","unstructured":"Kontogiorgis C, Valikeserlis I, Hadjipavlou-Litina D, Nena E, Constantinidis TC. Use of non-selective non-steroidal anti-inflammatory drugs in relation to cardiovascular events: a systematic pharmacoepidemiological review. Curr Vasc Pharmacol. 2016;14(6):502\u201313.","journal-title":"Curr Vasc Pharmacol"},{"issue":"2","key":"1555_CR41","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1093\/qjmed\/hcz307","volume":"113","author":"R Chokesuwattanaskul","year":"2020","unstructured":"Chokesuwattanaskul R, Chiengthong K, Thongprayoon C, Lertjitbanjong P, Bathini T, Ungprasert P, et al. Nonsteroidal anti-inflammatory drugs and incidence of atrial fibrillation: a meta-analysis. QJM. 2020;113(2):79\u201385.","journal-title":"QJM"},{"issue":"10","key":"1555_CR42","first-page":"1332","volume":"35","author":"P Meyre","year":"2019","unstructured":"Meyre P, Blum S, Berger S, Aeschbacher S, Schoepfer H, Briel M, et al. Risk of hospital admissions in patients with atrial fibrillation: a systematic review and meta-analysis. Can J Cardiol. 2019;35(10):1332\u201343.","journal-title":"Can J Cardiol"},{"issue":"7","key":"1555_CR43","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.amjmed.2019.01.003","volume":"132","author":"D Pastori","year":"2019","unstructured":"Pastori D, Farcomeni A, Pignatelli P, Violi F, Lip GY. ABC (Atrial fibrillation Better Care) pathway and healthcare costs in atrial fibrillation: the ATHERO-AF Study. Am J Med. 2019;132(7):856\u201361.","journal-title":"Am J Med"},{"issue":"4","key":"1555_CR44","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s00228-023-03470-y","volume":"79","author":"G Gazzaniga","year":"2023","unstructured":"Gazzaniga G, Menichelli D, Scaglione F, Farcomeni A, Pani A, Pastori D. Effect of digoxin on all-cause and cardiovascular mortality in patients with atrial fibrillation with and without heart failure: an umbrella review of systematic reviews and 12 meta-analyses. Eur J Clin Pharmacol. 2023;79(4):473\u201383.","journal-title":"Eur J Clin Pharmacol"},{"issue":"286","key":"1555_CR45","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.ijcard.2019.01.047","volume":"1","author":"R Doshi","year":"2019","unstructured":"Doshi R, Shah J, Desai R, Gullapalli N. Burden of arrhythmia in hospitalizations with opioid overdose. Int J Cardiol. 2019;1(286):73\u20135.","journal-title":"Int J Cardiol"},{"issue":"4","key":"1555_CR46","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2013-004059","volume":"4","author":"BP Krijthe","year":"2014","unstructured":"Krijthe BP, Heeringa J, Hofman A, Franco OH, Stricker BH. Non-steroidal anti-inflammatory drugs and the risk of atrial fibrillation: a population-based follow-up study. BMJ Open. 2014;4(4): e004059.","journal-title":"BMJ Open"},{"issue":"15","key":"1555_CR47","doi-asserted-by":"publisher","first-page":"E560","DOI":"10.1503\/cmaj.160355","volume":"189","author":"G Trifiro","year":"2017","unstructured":"Trifiro G, de Ridder M, Sultana J, Oteri A, Rijnbeek P, Pecchioli S, et al. Use of azithromycin and risk of ventricular arrhythmia. CMAJ. 2017;189(15):E560\u20138.","journal-title":"CMAJ"}],"container-title":["Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-025-01555-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40264-025-01555-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-025-01555-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T15:02:12Z","timestamp":1757516532000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40264-025-01555-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,18]]},"references-count":47,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["1555"],"URL":"https:\/\/doi.org\/10.1007\/s40264-025-01555-4","relation":{},"ISSN":["0114-5916","1179-1942"],"issn-type":[{"value":"0114-5916","type":"print"},{"value":"1179-1942","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,18]]},"assertion":[{"value":"4 May 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Open access funding provided by Universit\u00e0 degli Studi di Roma La Sapienza within the CRUI-CARE Agreement.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Danilo Menichelli, Gianluca Gazzaniga, Arianna Pannunzio, Ilaria Maria Palumbo, Arianna Pani, Pasquale Pignatelli, Emanuele Valeriani and Daniele Pastori have no relevant financial or non-financial interests to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethics approval was not required because of the study type.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Data supporting the conclusion of this article will be made available by the authors, without undue reservation.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"DM: conceptualisation, methodology, formal analysis, writing original draft. GG: methodology, writing original draft. AP: data curation, methodology, writing original draft. IMP: data curation, methodology, writing original draft. AP: revision of original draft, supervision. PP: revision of original draft, supervision. EV: methodology, formal analysis, writing original draft. DP: revision of original draft, supervision. All authors read and approved the latest version of the manuscript.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}